在恶性质瘤中,HLA类基因和抗原呈现分子的体质突变
Sara C Schulte1, Wolfgang Peter2, Georg Rosenberger3
1Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Cancer immunology research
|May 5, 2025
概括
质瘤免疫逃避涉及人类白细胞抗原 (HLA) 和抗原呈现基因的突变. 复发性质母细胞瘤显示突变增加,表明在瘤进展和免疫逃逸中发挥作用.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 免疫逃避是质瘤的一个关键特征,但瘤免疫逃避的遗传基础尚未完全理解.
- 了解这些机制对于开发有效的质瘤治疗至关重要.
研究的目的:
- 系统地研究人类白细胞抗原 (HLA) 基因和质瘤中的抗原呈现途径基因的体质突变.
- 探索这些突变在质瘤病理生理学和免疫逃生中的作用.
主要方法:
- 目标下一代测序 (NGS) 使用短读和长读技术.
- 用专门的生物信息学管道分析扩展的遗传区域 (外子和内子).
- 三维蛋白质建模以评估已识别的突变的影响.
主要成果:
- 在HLAII类,非经典的HLA基因,TAP1/2和B2M中发现了体性突变.
- 在复发性质母细胞瘤 (GBM) 中观察到这些突变的更高频率.
- 模拟了TAP1和B2M突变对蛋白质配置的结构影响.
结论:
- 抗原呈现基因中的体质突变有助于质瘤免疫逃生.
- 复发性GBM中突变频率的增加表明在瘤进展过程中存在积极选择.
- 这些发现为优化质瘤免疫疗法策略和个性化治疗提供了基础.
更多相关视频
相关概念视频
Antigens Involved in Adaptive Immunity
321
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
321
Cancers Originate from Somatic Mutations in a Single Cell
11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K


